SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A decent increase of about 29.84% in the sales to Rs. 1863.84 millions was observed for the quarter ended March 2023. The sales figure stood at Rs. 1435.44 millions during the year-ago period.Good  Net Profit growth of 27.63% reported above the corresponding previous quarter figure of Rs. 212.80 millions to Rs. 271.59 millioins.OP of the company witnessed a marginal growth to 406.44 millions from 259.63 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1863.84 1435.44 29.84 6167.34 5201.35 18.57 6167.34 5201.35 18.57
Other Income -1.74 1.76 -198.86 43.20 27.62 56.41 43.20 27.62 56.41
PBIDT 406.44 259.63 56.55 1269.82 1079.38 17.64 1269.82 1079.38 17.64
Interest 5.94 5.89 0.85 24.14 64.07 -62.32 24.14 64.07 -62.32
PBDT 400.50 253.74 57.84 1245.68 1015.31 22.69 1245.68 1015.31 22.69
Depreciation 34.27 31.12 10.12 123.42 100.80 22.44 123.42 100.80 22.44
PBT 366.23 222.62 64.51 1122.26 914.51 22.72 1122.26 914.51 22.72
TAX 94.64 9.82 863.75 288.82 195.04 48.08 288.82 195.04 48.08
Deferred Tax 5.96 0.47 1168.09 25.05 27.83 -9.99 25.05 27.83 -9.99
PAT 271.59 212.80 27.63 833.44 719.47 15.84 833.44 719.47 15.84
Equity 364.37 364.37 0.00 364.37 364.37 0.00 364.37 364.37 0.00
PBIDTM(%) 21.81 18.09 20.56 20.59 20.75 -0.78 20.59 20.75 -0.78

Acutaas Chemicals Share Price

2386.55 -35.95 (-1.48%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×